132 related articles for article (PubMed ID: 7928693)
1. Synthesis and in vitro antibacterial activities of 3-thiazol-4-yl-1-carba-1-dethiacephalosporins.
Hornback WJ; Munroe JE; Counter FT
J Antibiot (Tokyo); 1994 Sep; 47(9):1052-64. PubMed ID: 7928693
[TBL] [Abstract][Full Text] [Related]
2. [Specificities of antibacterial activity of zwitterionic 7-methoxyimino cephems (cephalosporins of fourth generation].
Pechère JC
Pathol Biol (Paris); 1996 Feb; 44(2):99-105. PubMed ID: 8761594
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of novel cephalosporins containing a (Z)-vinyl dimethylphosphonate group.
Smith PW; Chamiec AJ; Chung G; Cobley KN; Duncan K; Howes PD; Whittington AR; Wood MR
J Antibiot (Tokyo); 1995 Jan; 48(1):73-82. PubMed ID: 7868393
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antibacterial activity of 3-[N-methyl-N-(3-methyl-1,3-thiazolium-2-yl)aminolmethyl cephalosporin derivatives.
Kim SH; Son H; Nam G; Chi DY; Kim JH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1143-5. PubMed ID: 10866367
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activities of 2-oxaisocephems.
Tsubouchi H; Tsuji K; Yasumura K; Ishikawa H
Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2084-9. PubMed ID: 7805133
[TBL] [Abstract][Full Text] [Related]
7. Studies on beta-lactam antibiotics. I. Synthesis and in vitro anti-pseudomonal activity of 3-isothiazole-cephalosporin derivatives.
Nagano N; Nakano K; Shibanuma T; Murakami Y; Hara R
J Antibiot (Tokyo); 1987 Feb; 40(2):173-81. PubMed ID: 3106286
[TBL] [Abstract][Full Text] [Related]
8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
9. CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships.
Masakitsushima ; Iwamatsu K; Umemura E; Kudo T; Sato Y; Shiokawa S; Takizawa H; Kano Y; Kobayashi K; Ida T; Tamura A; Atsumi K
Bioorg Med Chem; 2000 Dec; 8(12):2781-9. PubMed ID: 11131169
[TBL] [Abstract][Full Text] [Related]
10. 3-Sulfonyl-1-carba-1-dethiacephems.
Crowell TA; Halliday BD; McDonald JH; Indelicato JM; Pasini CE; Wu EC
J Med Chem; 1989 Nov; 32(11):2436-42. PubMed ID: 2810332
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological properties of a series of optically active 2-oxaisocephems.
Tsubouchi H; Ishikawa H
Bioorg Med Chem; 1995 Feb; 3(2):143-50. PubMed ID: 7796047
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of C-3' isothiazolyl and related cephalosporins.
Skotnicki JS; Strike DP
J Antibiot (Tokyo); 1986 Mar; 39(3):380-3. PubMed ID: 3700239
[TBL] [Abstract][Full Text] [Related]
13. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
[TBL] [Abstract][Full Text] [Related]
14. A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships.
Yamawaki K; Nomura T; Yasukata T; Uotani K; Miwa H; Takeda K; Nishitani Y
Bioorg Med Chem; 2007 Nov; 15(21):6716-32. PubMed ID: 17723304
[TBL] [Abstract][Full Text] [Related]
15. A novel series of parenteral cephalosporins exhibiting potent activities against both Pseudomonas aeruginosa and other gram-negative pathogens. Part 2: Synthesis and structure-activity relationships.
Yamawaki K; Nomura T; Yasukata T; Tanimoto N; Uotani K; Miwa H; Yamano Y; Takeda K; Nishitani Y
Bioorg Med Chem; 2008 Feb; 16(4):1632-47. PubMed ID: 18065229
[TBL] [Abstract][Full Text] [Related]
16. Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787.
Miyake A; Yoshimura Y; Yamaoka M; Nishimura T; Hashimoto N; Imada A
J Antibiot (Tokyo); 1992 May; 45(5):709-20. PubMed ID: 1624373
[TBL] [Abstract][Full Text] [Related]
17. Studies on beta-lactam antibiotics. IV. An improved synthesis of 3-(isothiazolylthiomethyl)cephalosporins and its application to new derivatives.
Hara R; Nakai E; Hisamichi H; Nagano N
J Antibiot (Tokyo); 1994 Apr; 47(4):477-86. PubMed ID: 8195048
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones.
Vicini P; Geronikaki A; Anastasia K; Incerti M; Zani F
Bioorg Med Chem; 2006 Jun; 14(11):3859-64. PubMed ID: 16488614
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoyl-amino]-3- desacetoxymethylcephalosporins.
Ishikura K; Kubota T; Minami K; Hamashima Y; Nakashimizu H; Motokawa K; Yoshida T
J Antibiot (Tokyo); 1994 Apr; 47(4):453-65. PubMed ID: 8195046
[TBL] [Abstract][Full Text] [Related]
20. Orally active cephalosporins. Part 4: synthesis, structure--activity relationships and oral absorption of novel 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains.
Yamamoto H; Eikyu Y; Okuda S; Kawabata K; Takasugi H; Tanaka H; Matsumoto S; Matsumoto Y; Tawara S
Bioorg Med Chem; 2002 May; 10(5):1535-45. PubMed ID: 11886815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
